Literature DB >> 24481921

Autologous albumin enhances the humoral immune response to capsular polysaccharide covalently coattached to bacteria-sized latex beads.

Jesus Colino1, Leah Duke, Clifford M Snapper.   

Abstract

Abundant autologous proteins, like serum albumin, should be immunologically inert. However, individuals with no apparent predisposition to autoimmune disease can develop immune responses to autologous therapeutic proteins. Protein aggregation is a potential major trigger of these responses. Adsorption of proteins to particles provides macromolecular size and may generate structural changes in the protein, resembling aggregation. Using aldehyde/sulfate latex beads coated with murine serum albumin (MSA), we found that BALB/c mice mounted MSA-specific IgG responses that were dependent on CD4(+) T cells. IgGs were specific for MSA adsorbed to solid surfaces and noncross-reactive with human, bovine, or pig albumins. T cells induced in response to MSA augmented the primary and induced boosted secondary IgG and IgM responses specific for the T cell-independent antigen, capsular polysaccharide of Streptococcus pneumoniae type 14 (PPS14), when the latter was attached to the same bead. Similar to the anti-MSA IgG response, the boosted PPS14-specific IgG secondary response was CD4(+) T-cell dependent, displayed a typical carrier effect, and was enhanced by, but did not require, Toll-like receptor stimulation. These results provide a potential mechanism for the induction of responses to autoantigens unable to induce specific T-cell responses, and provide new insights into polysaccharide-specific immunity. Published 2014. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  Autoimmunity; Autoreactive memory responses; Humoral responses; Immunity to bacteria

Mesh:

Substances:

Year:  2014        PMID: 24481921      PMCID: PMC4004682          DOI: 10.1002/eji.201344266

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  47 in total

1.  The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors.

Authors:  A Ozinsky; D M Underhill; J D Fontenot; A M Hajjar; K D Smith; C B Wilson; L Schroeder; A Aderem
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

2.  Glycation induces formation of amyloid cross-beta structure in albumin.

Authors:  Barend Bouma; Loes M J Kroon-Batenburg; Ya-Ping Wu; Bettina Brünjes; George Posthuma; Onno Kranenburg; Philip G de Groot; Emile E Voest; Martijn F B G Gebbink
Journal:  J Biol Chem       Date:  2003-08-08       Impact factor: 5.157

3.  Genetic remodeling of protein glycosylation in vivo induces autoimmune disease.

Authors:  D Chui; G Sellakumar; R Green; M Sutton-Smith; T McQuistan; K Marek; H Morris; A Dell; J Marth
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

4.  Cell activation by Porphyromonas gingivalis lipid A molecule through Toll-like receptor 4- and myeloid differentiation factor 88-dependent signaling pathway.

Authors:  Tomohiko Ogawa; Yasuyuki Asai; Masahito Hashimoto; Osamu Takeuchi; Tomoko Kurita; Yasunobu Yoshikai; Kensuke Miyake; Shizuo Akira
Journal:  Int Immunol       Date:  2002-11       Impact factor: 4.823

5.  Thrombocytopenia caused by the development of antibodies to thrombopoietin.

Authors:  J Li; C Yang; Y Xia; A Bertino; J Glaspy; M Roberts; D J Kuter
Journal:  Blood       Date:  2001-12-01       Impact factor: 22.113

6.  Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin.

Authors:  Nicole Casadevall; Joelle Nataf; Beatrice Viron; Amir Kolta; Jean-Jacques Kiladjian; Philippe Martin-Dupont; Patrick Michaud; Thomas Papo; Valerie Ugo; Irene Teyssandier; Bruno Varet; Patrick Mayeux
Journal:  N Engl J Med       Date:  2002-02-14       Impact factor: 91.245

7.  Activation of autoreactive B cells by CpG dsDNA.

Authors:  Gregory A Viglianti; Christina M Lau; Timothy M Hanley; Benjamin A Miko; Mark J Shlomchik; Ann Marshak-Rothstein
Journal:  Immunity       Date:  2003-12       Impact factor: 31.745

8.  Serum interferon (IFN)-neutralizing antibodies and bioactivities of IFNs in patients with severe type II essential mixed cryoglobulinemia.

Authors:  Carolina Scagnolari; Milvia Casato; Francesca Bellomi; Francesca De Pisa; Ombretta Turriziani; Rossella Coviello; Maria Rosaria Pirro; Ferdinando Dianzani; Guido Antonelli
Journal:  Clin Diagn Lab Immunol       Date:  2003-01

9.  An inherited albumin variant in the house mouse, Mus musculus.

Authors:  M L Petras
Journal:  Biochem Genet       Date:  1972-12       Impact factor: 1.890

10.  Carrier function in anti-hapten immune responses. I. Enhancement of primary and secondary anti-hapten antibody responses by carrier preimmunization.

Authors:  D H Katz; W E Paul; E A Goidl; B Benacerraf
Journal:  J Exp Med       Date:  1970-08-01       Impact factor: 14.307

View more
  3 in total

1.  Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors.

Authors:  Julie M Shabto; Dylan J Martini; Yuan Liu; Deepak Ravindranathan; Jacqueline Brown; Emilie E Hitron; Greta A Russler; Sarah Caulfield; Haydn Kissick; Mehrdad Alemozaffar; Kenneth Ogan; Wayne B Harris; Viraj A Master; Omer Kucuk; Bradley C Carthon; Mehmet A Bilen
Journal:  Cancer Med       Date:  2020-02-25       Impact factor: 4.452

Review 2.  Distinct Immunologic Properties of Soluble Versus Particulate Antigens.

Authors:  Clifford M Snapper
Journal:  Front Immunol       Date:  2018-03-21       Impact factor: 7.561

Review 3.  Protein Supramolecular Structures: From Self-Assembly to Nanovaccine Design.

Authors:  Ximena Zottig; Mélanie Côté-Cyr; Dominic Arpin; Denis Archambault; Steve Bourgault
Journal:  Nanomaterials (Basel)       Date:  2020-05-25       Impact factor: 5.076

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.